Journal rankings · indicator year 2020
Choose a field to open its ranking, or a journal to find its row in its subfield’s list.
Subfield ranking · 2020
Immunology journal rankings 2020
92 ranked journals · Subfield in Immunology and Microbiology
Immunology has 92 ranked journals in 2020. The median journal has an OJR of 0.93, below the world average of 1.00, down 0.04 on 2019; Q1 starts at OJR 1.44. The top three are Immunity, Seminars in Immunopathology, and Nature Immunology.
Ranks and citation indicators: 2020. Journal access status and listed APC: source snapshot September 23, 2026.
Journals whose main subfield sits in this category and that published at least 30 citable documents (articles, reviews and conference papers) in 2017–2019, the window the 2020 score is computed on.
The OpenJournalRank Indicator (OJR) is a free, publicly available metric of a journal’s field-normalized citation impact, computed from open OpenAlex citation data. It compares citations to a journal’s papers from the previous three years with the world average for papers of the same subfield, year and type, so 1.00 is the world average and values can be compared across fields. It is computed with the NCI3 method.
The middle OJR among ranked journals in this category: half score higher, half lower. 1.00 is the world average for papers of the same subfield, year and type.
The dot is this category, the solid tick is the median of all ranked journals and the dashed line is the world average.
Share of ranked journals in this category that are fully open access, so every paper is free to read. Hybrid journals, which sell subscriptions and open single papers for a fee, are not counted.
Median list price of the article processing charge, in US dollars, among ranked journals in this category that list a price above zero. Journals with a listed APC of $0 and journals with no known price are left out of this median. The At a glance table below gives a second median that includes the $0 prices.
Subfields of Immunology and Microbiology (5)
92 ranked journals
Filters
Rank is the position by OJR within the list on screen; 1 is the highest. | OJR is field-normalized 3-year citation impact: 1.00 is the world average for papers of the same subfield, year and type, so values compare across fields. The badge is the journal’s quartile in this list. | Citations per paper over a two-year window, counted from OpenAlex. It is not field-normalized, so compare it only between journals of the same field. ▲ or ▼ is the change from 2019. This is OpenJournalRank’s own count, not Clarivate’s Journal Impact Factor. | Citable documents (articles, reviews and conference papers) published in 2017–2019, the window the 2020 OJR is computed on. A journal needs at least 30 to be ranked. | Share of the journal’s 2017–2019 papers that are free to read in any open-access form. The green OA tag next to a title marks a fully open-access journal. | List price of the article processing charge in US dollars. “$0 listed” means the listed price is zero; a dash means no price is listed. | The line is the journal’s OJR from 2011 to 2020. | Compare |
|---|---|---|---|---|---|---|---|
1ImmunityCell Press · United States | 5.64Q1 | 22.30 5.62 up from 2019 | 753 | 97% | $10,400 | ||
2Seminars in ImmunopathologySpringer Science+Business Media · Germany | 4.91Q1 | 9.60 1.54 up from 2019 | 152 | 84% | $3,790 | ||
3Nature ImmunologyNature Portfolio · United States | 4.11Q1 | 15.17 3.04 up from 2019 | 693 | 57% | $12,690 | ||
4The Journal of Experimental MedicineRockefeller University Press · United States | 3.52Q1 | 12.42 0.23 up from 2019 | 717 | 98% | — | ||
5Science ImmunologyAmerican Association for the Advancement of Science · United States | 3.44Q1 | 13.19 2.62 up from 2019 | 315 | 62% | — | ||
6Seminars in ImmunologyElsevier BV · United States | 3.42Q1 | 11.38 1.17 up from 2019 | 163 | 74% | $4,370 | ||
7Clinical Reviews in Allergy & ImmunologySpringer Nature · United States | 3.27Q1 | 9.54 1.38 up from 2019 | 168 | 38% | $5,490 | ||
8Nature reviews. ImmunologyNature Portfolio · United Kingdom | 3.11Q1 | 19.29 3.06 up from 2019 | 450 | 66% | — | ||
9Journal of Allergy and Clinical ImmunologyElsevier BV · United States | 2.47Q1 | 7.45 0.15 down from 2019 | 1,592 | 82% | $4,900 | ||
10Annual Review of ImmunologyAnnual Reviews · United States | 2.42Q1 | 31.80 9.29 up from 2019 | 73 | 38% | — | ||
11Journal of AutoimmunityElsevier BV · United Kingdom | 2.29Q1 | 7.43 0.10 down from 2019 | 394 | 56% | $5,420 | ||
12Frontiers in ImmunologyOAFrontiers Media · Switzerland | 2.23Q1 | 8.75 2.51 up from 2019 | 7,915 | 100% | $3,801 | ||
13Mucosal ImmunologyOAElsevier BV · United States | 2.23Q1 | 7.14 0.58 up from 2019 | 362 | 100% | $4,370 | ||
14Immunity & AgeingOABioMed Central · United Kingdom | 1.98Q1 | 7.40 3.42 up from 2019 | 84 | 100% | $3,190 | ||
15Journal of Innate ImmunityOAKarger Publishers · Switzerland | 1.86Q1 | 6.62 2.47 up from 2019 | 165 | 100% | $3,590 | ||
16Clinical & Translational ImmunologyOAWiley · Australia | 1.85Q1 | 6.52 0.74 up from 2019 | 113 | 100% | $3,070 | ||
17International Journal of InflammationOAHindawi Publishing Corporation · United Kingdom | 1.84Q1 | 6.94 2.82 up from 2019 | 40 | 100% | $1,000 | ||
18ImmunologyWiley · United Kingdom | 1.75Q1 | 7.62 2.34 up from 2019 | 442 | 89% | $5,330 | ||
19Immune NetworkOASouth Korea | 1.73Q1 | 6.51 2.12 up from 2019 | 139 | 100% | — | ||
20BioDrugsAdis, Springer Healthcare · Switzerland | 1.73Q1 | 6.63 0.41 up from 2019 | 172 | 63% | $5,190 | ||
21The Journal of ImmunologyAmerican Association of Immunologists · United States | 1.55Q1 | 5.07 0.04 up from 2019 | 2,256 | 13% | $3,500 | ||
22International Reviews of ImmunologyTaylor & Francis · United States | 1.50Q1 | 4.02 1.42 down from 2019 | 79 | 12% | — | ||
23International ImmunologyOxford University Press · United Kingdom | 1.44Q1 | 4.21 1.32 up from 2019 | 271 | 42% | $3,530 | ||
24Cellular and Molecular ImmunologySpringer Nature · China | 1.41Q2 | 6.25 2.30 up from 2019 | 428 | 100% | $5,190 | ||
25Clinical & Experimental ImmunologyOxford University Press · United Kingdom | 1.37Q2 | 4.53 0.82 up from 2019 | 445 | 92% | $3,816 | ||
26Cellular ImmunologyElsevier BV · Netherlands | 1.36Q2 | 4.81 0.40 up from 2019 | 356 | 40% | $3,550 | ||
27The AAPS JournalSpringer Science+Business Media · United States | 1.35Q2 | 3.98 0.25 down from 2019 | 350 | 43% | $5,090 | ||
28Trends in ImmunologyElsevier BV · United Kingdom | 1.35Q2 | 12.46 0.06 up from 2019 | 299 | 61% | $7,030 | ||
29BMC ImmunologyOABioMed Central · United Kingdom | 1.34Q2 | 4.03 0.90 up from 2019 | 144 | 100% | $3,090 | ||
30Expert Opinion on Biological TherapyTaylor & Francis · United Kingdom | 1.33Q2 | 4.53 1.01 up from 2019 | 410 | 33% | — | ||
31Journal of Leukocyte BiologyOxford University Press · United States | 1.29Q2 | 4.82 0.97 up from 2019 | 652 | 46% | $3,800 | ||
32Immunological ReviewsWiley · United States | 1.27Q2 | 9.68 5.04 down from 2019 | 300 | 60% | $5,000 | ||
33Inflammation ResearchSpringer Science+Business Media · Switzerland | 1.27Q2 | 4.77 1.41 up from 2019 | 274 | 30% | $4,790 | ||
34Molecular ImmunologyElsevier BV · Netherlands | 1.27Q2 | 4.24 0.37 up from 2019 | 819 | 25% | $3,340 | ||
35Drugs in R&DOAAdis, Springer Healthcare · New Zealand | 1.25Q2 | 2.72no change | 119 | 100% | $3,490 | ||
36Journal of Clinical ImmunologySpringer Science+Business Media · United States | 1.11Q2 | 3.62 1.78 down from 2019 | 334 | 47% | $4,990 | ||
37CytokineElsevier BV · United Kingdom | 1.11Q2 | 3.82 1.04 up from 2019 | 970 | 20% | $3,220 | ||
38Immunology and Cell BiologyWiley · Australia | 1.10Q2 | 4.65 1.06 up from 2019 | 288 | 62% | $3,750 | ||
39Immunology LettersElsevier BV · Netherlands | 1.10Q2 | 3.59 0.05 up from 2019 | 441 | 24% | $3,290 | ||
40Journal of ImmunotoxicologyOAInforma · United States | 1.06Q2 | 2.88 0.12 down from 2019 | 63 | 100% | $2,306 | ||
41European Journal of ImmunologyWiley · Germany | 1.05Q2 | 3.59 0.37 up from 2019 | 710 | 87% | $4,550 | ||
42Clinical ImmunologyElsevier BV · Netherlands | 1.04Q2 | 3.43 0.11 up from 2019 | 519 | 44% | $4,400 | ||
43American Journal of Reproductive ImmunologyWiley · United Kingdom | 1.00Q2 | 3.44 0.57 up from 2019 | 447 | 35% | $4,460 | ||
44Psoriasis Targets and TherapyOADove Medical Press · New Zealand | 0.99Q2 | 3.88 0.16 up from 2019 | 33 | 100% | $2,320 | ||
45Fish & Shellfish ImmunologyElsevier BV · United Kingdom | 0.98Q2 | 4.44 0.15 up from 2019 | 2,343 | 12% | $4,330 | ||
46Immunologic ResearchSpringer Science+Business Media · United States | 0.95Q2 | 3.28 0.31 up from 2019 | 222 | 30% | $2,890 | ||
47Current Protocols in ImmunologyWiley · United States | 0.91Q3 | 3.83 1.40 up from 2019 | 67 | 75% | $5,050 | ||
48ImmunobiologyOAElsevier BV · Germany | 0.89Q3 | 2.75 0.08 up from 2019 | 302 | 29% | $2,840 | ||
49Genes and ImmunitySpringer Nature · United States | 0.88Q3 | 3.14 0.43 up from 2019 | 105 | 55% | $3,190 | ||
50ImmunoHorizonsOAUnited States | 0.88Q3 | 3.58 1.31 up from 2019 | 111 | 100% | $1,700 |
Subfields of Immunology and Microbiology, with Immunology highlighted.
Journals
Citations made in 2020. Corpus-wide, 86.1% of core-journal articles and reviews published that year have at least one matched reference; the share varies by journal and field.
33 additional Immunology journals with metrics are unranked under this release’s eligibility rules: a journal needs at least 30 citable documents in 2017–2019, at least 80% of them with a subfield, and a positive world-average expectation. Ranks are within the whole category; filters hide rows without re-ranking. OJR excludes self-citations.
At a glance
Indicator year: 2020. Publication window: 2017–2019. How these summaries are calculated
- Ranked journals
- 92
- Window papers (baseline)
- 74,045 +1.7% from indicator year 2017
- Median OJR
- 0.931 -2.5% from indicator year 2017
- Rising journals (2025)
- 5
Window papers are the baseline paper population: citable papers (articles, reviews and conference papers) from 2017–2019 in all journals of the world-average baseline, including non-core journals, counted by each paper’s own subfield. They are not the papers of the ranked journals alone.
| Measure | Year series | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ranked journals | 56 | 59 | 63 | 65 | 62 | 64 | 68 | 72 | 71 | 74 | 76 | 79 | 81 | 86 | 83 | 88 | 90 | 96 | 94 | 90 | 92 | 87 | 88 | 88 | 88 | 86 | |
| Window papers (baseline) | 33,673 | 35,811 | 37,963 | 40,362 | 42,065 | 44,849 | 47,600 | 50,960 | 53,923 | 57,726 | 63,072 | 65,596 | 67,601 | 67,579 | 70,684 | 72,624 | 73,354 | 72,790 | 72,098 | 72,447 | 74,045 | 77,362 | 81,615 | 83,779 | 84,353 | 84,391 | |
| Median OJR | 0.72 | 0.78 | 0.834 | 0.82 | 0.830 | 0.88 | 0.89 | 0.959 | 1.002 | 1.15 | 1.100 | 1.09 | 1.096 | 1.04 | 1.08 | 1.06 | 1.05 | 0.95 | 0.921 | 0.970 | 0.931 | 0.932 | 0.967 | 0.956 | 0.922 | 0.87 |
How to read these rankings
- OJR, the OpenJournalRank Indicator
- A field-normalized 3-year citation impact, computed from OpenAlex with the NCI3 method. It divides the citations a journal’s papers received by the world average for papers of the same subfield, year and type, so 1.00 is the world average and 2.00 means twice as many citations as expected. Because it is normalized, it can be compared across fields. Read the methodology
- Quartiles
- Q1 to Q4 split the ranked journals of the list you are viewing into four equal groups by OJR. A journal’s quartile depends on the list: the same journal can be Q1 in its subfield and Q2 among all journals.
- Impact factor (2-year)
- Citations per paper over a two-year window, counted from OpenAlex. It is easy to compare with familiar impact factors but is not field-normalized, so compare it only within a field. It is not Clarivate’s Journal Impact Factor. Why it differs from the Journal Impact Factor
- Rank ranges
- Each rank in the latest year carries a likely range from 1,000 resamples of the journal’s papers. Where two journals’ ranges overlap, the data cannot tell them apart, so treat neighbouring ranks as ties.